Retraction Note: BRD9 inhibition promotes PUMA-dependent apoptosis and augments the effect of imatinib in gastrointestinal stromal tumors.
作者信息
Mu Jianfeng, Sun Xuezeng, Zhao Zhipeng, Sun Hao, Sun Pengda
机构信息
Department of Gastric and Colorectal Surgery, The First Hospital of Jilin University, Changchun, China.
Department of Gastrointestinal Nutrition and Hernia Surgery, The Second Hospital of Jilin University, Changchun, China.
出版信息
Cell Death Dis. 2025 Jun 5;16(1):435. doi: 10.1038/s41419-025-07756-0.
Abstract
摘要
相似文献
1
Retraction Note: BRD9 inhibition promotes PUMA-dependent apoptosis and augments the effect of imatinib in gastrointestinal stromal tumors.撤稿说明：BRD9抑制促进PUMA依赖的细胞凋亡并增强伊马替尼在胃肠道间质瘤中的作用。
Cell Death Dis. 2025 Jun 5;16(1):435. doi: 10.1038/s41419-025-07756-0.
2
BRD9 inhibition promotes PUMA-dependent apoptosis and augments the effect of imatinib in gastrointestinal stromal tumors.BRD9 抑制促进 PUMA 依赖性细胞凋亡，并增强伊马替尼治疗胃肠道间质瘤的效果。
Cell Death Dis. 2021 Oct 19;12(11):962. doi: 10.1038/s41419-021-04186-6.
3
Mitochondrial Inhibition Augments the Efficacy of Imatinib by Resetting the Metabolic Phenotype of Gastrointestinal Stromal Tumor.线粒体抑制通过重置胃肠道间质瘤的代谢表型增强伊马替尼的疗效。
Clin Cancer Res. 2018 Feb 15;24(4):972-984. doi: 10.1158/1078-0432.CCR-17-2697. Epub 2017 Dec 15.
4
Role for the proapoptotic factor BIM in mediating imatinib-induced apoptosis in a c-KIT-dependent gastrointestinal stromal tumor cell line.促凋亡因子 BIM 在介导 c-KIT 依赖性胃肠道间质肿瘤细胞系伊马替尼诱导的细胞凋亡中的作用。
J Biol Chem. 2010 May 7;285(19):14109-14. doi: 10.1074/jbc.M109.078592. Epub 2010 Mar 15.
5
Retraction Note: Copanlisib promotes growth inhibition and apoptosis by modulating the AKT/FoxO3a/PUMA axis in colorectal cancer.撤稿说明：库潘尼西通过调节结直肠癌中的AKT/FoxO3a/PUMA轴促进生长抑制和细胞凋亡。
Cell Death Dis. 2025 Apr 29;16(1):352. doi: 10.1038/s41419-025-07679-w.
6
Glucose transporter‑1 inhibition overcomes imatinib resistance in gastrointestinal stromal tumor cells.葡萄糖转运蛋白-1 抑制克服胃肠道间质瘤细胞对伊马替尼的耐药性。
Oncol Rep. 2022 Jan;47(1). doi: 10.3892/or.2021.8218. Epub 2021 Nov 5.
7
The synergistic therapeutic effect of imatinib and protein kinase CK2 Inhibition correlates with PI3K-AKT activation in gastrointestinal stromal tumors.伊马替尼与蛋白激酶 CK2 抑制的协同治疗效果与胃肠道间质瘤中 PI3K-AKT 的激活相关。
Clin Res Hepatol Gastroenterol. 2022 Jun-Jul;46(6):101886. doi: 10.1016/j.clinre.2022.101886. Epub 2022 Feb 18.
8
Advanced gastrointestinal stromal tumors successfully treated with imatinib mesylate: a report of two cases.甲磺酸伊马替尼成功治疗晚期胃肠道间质瘤：两例报告
J Natl Med Assoc. 2003 Dec;95(12):1208-10.
9
Depletion of telomerase RNA inhibits growth of gastrointestinal tumors transplanted in mice.端粒酶 RNA 的耗竭抑制了移植于小鼠的胃肠道肿瘤的生长。
World J Gastroenterol. 2013 Apr 21;19(15):2340-7. doi: 10.3748/wjg.v19.i15.2340.
10
Imatinib-resistant gastrointestinal stromal tumors in the era of second- and third-line tyrosine kinase inhibitors: Does surgical resection have a role?二线和三线酪氨酸激酶抑制剂时代的伊马替尼耐药胃肠道间质瘤：手术切除有作用吗？
Surgery. 2021 Nov;170(5):1481-1486. doi: 10.1016/j.surg.2021.05.009. Epub 2021 Jun 2.
本文引用的文献
1
Copanlisib promotes growth inhibition and apoptosis by modulating the AKT/FoxO3a/PUMA axis in colorectal cancer.考潘立昔布通过调节结直肠癌中的 AKT/FoxO3a/PUMA 轴促进生长抑制和细胞凋亡。
Cell Death Dis. 2020 Nov 2;11(11):943. doi: 10.1038/s41419-020-03154-w.
2
SETDB1 promotes glioblastoma growth via CSF-1-dependent macrophage recruitment by activating the AKT/mTOR signaling pathway.SETDB1通过激活AKT/mTOR信号通路，依赖集落刺激因子1（CSF-1）招募巨噬细胞，从而促进胶质母细胞瘤的生长。
J Exp Clin Cancer Res. 2020 Oct 15;39(1):218. doi: 10.1186/s13046-020-01730-8.
3
MEK inhibitors induce apoptosis via FoxO3a-dependent PUMA induction in colorectal cancer cells.MEK抑制剂通过依赖FoxO3a的PUMA诱导在结肠癌细胞中诱导凋亡。
Oncogenesis. 2018 Sep 7;7(9):67. doi: 10.1038/s41389-018-0078-y.
Zotero 插件